Which statement accurately describes the handling of cysteine in PN formulations due to its chemical properties?

Which statement accurately describes the handling of cysteine in PN formulations due to its chemical properties?

• A. It is unstable in aqueous solutions and must be added just before administration
• B. It is stable in all PN formulations
• C. It is unstable in lipid emulsions
• D. It is a standard component in all PN solutions

Answer: (B)

Cysteine carries a free sulfhydryl group, which makes it readily oxidize in aqueous IV solutions. This instability means the free cysteine can degrade, form disulfides, or cause solution changes if exposed to air or improper conditions. To ensure the patient receives the intended amount, cysteine is typically added at the end of PN preparation or prepared fresh for administration, often in a form and at a pH that keep it soluble and minimize oxidation. Because of this sensitivity, cysteine is not a universal component in every PN formulation, and its presence depends on the specific amino acid needs and preparation plan. The primary concern is its stability in the aqueous PN solution, not its behavior in lipid emulsions.

Cysteine carries a free sulfhydryl group, which makes it readily oxidize in aqueous IV solutions. This instability means the free cysteine can degrade, form disulfides, or cause solution changes if exposed to air or improper conditions. To ensure the patient receives the intended amount, cysteine is typically added at the end of PN preparation or prepared fresh for administration, often in a form and at a pH that keep it soluble and minimize oxidation. Because of this sensitivity, cysteine is not a universal component in every PN formulation, and its presence depends on the specific amino acid needs and preparation plan. The primary concern is its stability in the aqueous PN solution, not its behavior in lipid emulsions.